مواقع التدريسيينجامعة الكوفة
هيلين فارس مرزوك المنتفكي
مدرس

هيلين فارس مرزوك المنتفكي

English Version
0بحث منشور
0محاضرة

الملف الشخصي

 حاصلة على شهادة البكلوريوس في الصيدلة من جامعة الكوفة
للعام 2012

 صيدلانية متدربة في مستشفى النسائية والاطفال في محافظة
الديوانية من العام 2012 لغاية 2014

 معيدة ومحاضرة في كلية الصيدلة جامعة الكوفة فرع الصيدلة
السريرية في مختبر الصيدلة السريرية للمرحلة الرابعة وتدريب
المستشفى للمرحلة الخامسة ومبادى الصيدلة للمرحلة الاولى من
سنة 2014 لغاية 2017

 حاصلة على شهادة الماجستير في العلوم الصيدلانية من كلية
الصيدلة /الجامعة المستنصرية سنة 2019

 مدرس في فرع الصيدلة السريرية في جامعة الكوفة /
كلية الصيدلة من سنة 2019 لغاية الان

البحوث المنشورة

2
2021

Improvement of hospital discharge summary among patients with moderate to severe acute heart failure: Pharmacist –based intervention

الباحثونHelen Faris، MANAL KHALID ABDULRIDHA, SHOKRY FAAZ NASSIR
المجلةINTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH
مختصر البحث

Background: Acute decompensated heart failure keep rising in prevalence and it is an alarming state associated with poor prognosis, re-hospitalization and linked to major mortality and morbidity. Patients with acute heart failure are candidate for medication therapy management since being at high risk for developing adverse drug reaction and medication errors because of poly pharmacy. Accumulating evidence suggests benefits for clinical pharmacists’ participation in intensive care unit (ICU)/coronary care unit (CCU) consultation, and as members of outpatient health-care services. Objective: Evaluating pharmacist- based management strategies for patients with acute heart failure via improving summary discharge aimed to reducing hospital readmission, enhancing medications adherence and improve quality of life. Patients and Methods: This prospective study was carried out under intervention pharmacist- based program carried out on 50 patients whom completed this study, they were randomly allocated into two groups, program group(25 patients) who are receiving program for assessment and review starting from 30 minutes pre hospital discharge, then during subsequent post hospital discharge visits that starting with visit 1 (2 weeks), visits 2 (4 weeks), visits 3 (8weeks) and visits 4 (12 weeks). The control group(25 patients) on usual care which was physician based discharge summary and routine lab test without pharmacist intervention. Both study groups assessed for self care heart failure index, patient medications adherence and quality of life. Also laboratory assessment of prognostic biomarkers brain natriuretic peptide and cardiac troponin I and clinical vital signs(BP and HR) and EF were measured pre and post hospital discharge after 12 weeks. Result: Study findings revealed significant improvement in all self care heart failure index domains score (P=0.001) after 12 weeks post hospital discharge of pharmacist intervention, also increased in domains of belief medication questionnaire whether specific necessity and specific concern domains (P=0.001) or decreased in general harm and general overuse(p=0.001).Moreover, increase in all domains of WHO quality of life questionnaire (WHOQOL) (P=0.001). Both serum brain natriuretic peptide (P=0.001) and cardiac troponin I (P=0.001) level were decreased and ejection fraction was improved (P=0.01). Furthermore, pharmacist intervention and follow up for program patients resulted in reduced hospital readmission (24% vs 60%) and mortality (4% vs 12%) compared to usual care patients respectively. Conclusion: Implementing pharmacist- based management strategies for patients with acute heart failure via discharge summary markedly improve disease awareness, medication adherence, reduced hospital readmission and total mortality at the study endline among intervention patients compared to the usual care, reflecting the endpoint of the pharmacist-based intervention. Keyword: clinical pharmacist, intervention, acute heart failure, re-hospitalization, follow-up, Role.

2019

Assessment of Pharmacist Intervention Among Post Hospital Discharge Patients with Moderate and Severe Acute Heart Failure

الباحثونHelen Faris Marzoog ، Manal Khalid Abdulridha Shokry Faaz Nassir
المجلةAl-Mustansiriyah Journal for Pharmaceutical Sciences مجلة المستنصرية للعلوم الصيدلانية
مختصر البحث

Background: Acute heart failure is the most common cause for hospitalization and the third highest cause of hospital readmission with nearly quarter of patients being re hospitalized within 30 days after discharge. Implementation of Clinical pharmacists in coordinatedinpatient care, discharge planning and outpatient care result in significant improvements in adverse drug events reduction, medication adherence, quality of life and patient knowledge.Objective: Evaluating pharmacist- based program for patients with moderate and sever acute heart failure via improving summary discharge in reduction hospital readmission, enhancing medications adherence and improve quality of life.Patients and Methods: This prospective study was carried out under interventional pharmacist- based program carried out on 50 patients whom completed this study, they were randomly allocated to two groups, program group who are receiving program for assessment and review starting from 30 minutes pre hospital discharge till 12 weeks. The control group on usual care which include physician-based discharge summary, routine laboratory test without pharmacist intervention (25 patients for each group). Result: After 12 weeks of follow up among program patients in comparison with control group, study findings revealed significant improvement in self-care heart failure index domains (maintenance, management, confidence and total SCHFI score (P=0.001) in both moderate heart failure (NYHAIII) and severe heart failure (NYHAIV) groups, also increase in domains of belief medication questionnaire whether specific necessity and specific concern domains (P=0.001) or decreased in general harm and general overuse (P=0.001) in both moderate and severe heart failure. Moreover, increase in all domains of WHO quality of life questionnaire (WHOQOL) (P=0.001) in both moderate and sever heart failure with predominant improvement in moderate heart failure. Both serum brain natriuretic peptide (P=0.001) and cardiac troponin I (P<0.01) level were decreased in patients with moderate and severe HF and ejection fraction was improved (P=0.03) only among patients with severe HF of program group.Conclusion: Implementing pharmacist- based management program for patients with moderate and severe acute heart failure via summary discharge markedly improve disease awareness, medication adherence, reduced hospital readmission and total mortality at the end-line of study among intervention patients compared to the usual care

المحاضرات

13
عرض التفاصيل